Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
125M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
36.9M
-
Shares change
-
+19.8M
-
Total reported value, excl. options
-
$194M
-
Value change
-
+$105M
-
Number of buys
-
45
-
Number of sells
-
-12
-
Price
-
$5.26
Significant Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q1 2019
67 filings reported holding MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2019.
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.9M shares
of 125M outstanding shares and own 29.61% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (11.9M shares), Sarissa Capital Management LP (3.75M shares), ArrowMark Colorado Holdings LLC (3.22M shares), BVF INC/IL (2.5M shares), EcoR1 Capital, LLC (2.3M shares), ORBIMED ADVISORS LLC (1.89M shares), Point72 Asset Management, L.P. (1.53M shares), VANGUARD GROUP INC (1.5M shares), Rock Springs Capital Management LP (1.4M shares), and WELLINGTON MANAGEMENT GROUP LLP (966K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.